RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Acute Lung Injury
Accession: DOID:9004610
browse the term
Definition: A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).
Synonyms: exact_synonym: Acute Lung Injuries
primary_id: MESH:D055371 ; RDO:0007706
xref: EFO:0004610
G
ACE
angiotensin I converting enzyme
treatment
ISO
associated wit Escherichia coli Infections
RGD
PMID:29990483
RGD:40400897
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ACE2
angiotensin converting enzyme 2
severity treatment
ISO IDA EXP
human protein in a mouse model associated with avian influenza;protein:decreased expression:lung (mouse) associated with Escherichia coli Infections CTD Direct Evidence: therapeutic
CTD RGD
PMID:27302421 PMID:16001071 PMID:16001071 PMID:25391767 PMID:29990483
RGD:32716389 , RGD:32716389 , RGD:40818412 , RGD:40400897
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
ACVR1
activin A receptor type 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297076
NCBI chr 2:157,736,446...157,876,330
Ensembl chr 2:157,736,251...157,876,330
G
ADAR
adenosine deaminase RNA specific
treatment
ISO
RGD
PMID:18520702
RGD:10755331
NCBI chr 1:154,582,057...154,627,997
Ensembl chr 1:154,581,695...154,628,013
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
treatment
ISO
associated with Sepsis
RGD
PMID:22156343 PMID:23522481
RGD:5686380 , RGD:8695940
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ADRA2A
adrenoceptor alpha 2A
ISO
RGD
PMID:21542970
RGD:6480481
NCBI chr10:111,077,029...111,080,907
Ensembl chr10:111,077,029...111,080,907
G
AFF4
ALF transcription elongation factor 4
treatment
ISO
RGD
PMID:31466050
RGD:155631268
NCBI chr 5:132,875,395...132,963,634
Ensembl chr 5:132,875,395...132,963,634
G
AGER
advanced glycosylation end-product specific receptor
ISO
associated with Hyperoxia; protein:decreased expression:bronchoalveolar lavage fluid (rat)
RGD
PMID:23576805
RGD:7244254
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
AKAP12
A-kinase anchoring protein 12
ISO
mRNA,protein:increased expression:lung
RGD
PMID:23912647
RGD:14348970
NCBI chr 6:151,239,967...151,358,559
Ensembl chr 6:151,239,967...151,358,559
G
AKT1
AKT serine/threonine kinase 1
severity
ISO
RGD
PMID:23904165
RGD:38676478
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
ALB
albumin
ISO
RGD
PMID:22592748
RGD:6483494
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
ALOX15
arachidonate 15-lipoxygenase
ISO
RGD
PMID:19752233
RGD:5509626
NCBI chr17:4,630,919...4,641,678
Ensembl chr17:4,630,919...4,642,294
G
APOA1
apolipoprotein A1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:20972769
NCBI chr11:116,835,751...116,837,622
Ensembl chr11:116,835,751...116,837,622
G
AQP5
aquaporin 5
ISO
associated with Disseminated Intravascular Coagulation;mRNA,protein:decreased expression:lung:
RGD
PMID:24806323
RGD:11553933
NCBI chr12:49,961,872...49,965,682
Ensembl chr12:49,961,872...49,965,682
G
ASCL1
achaete-scute family bHLH transcription factor 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:20554700
NCBI chr12:102,957,674...102,960,513
Ensembl chr12:102,957,674...102,960,513
G
BAX
BCL2 associated X, apoptosis regulator
ISO
associated with Endotoxemia
RGD
PMID:20663300
RGD:10054109
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
ISO
associated with Endotoxemia
RGD
PMID:20663300
RGD:10054109
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
C3
complement C3
treatment
ISO
RGD
PMID:22763771
RGD:11040808
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CASC2
cancer susceptibility 2
IMP
human pcDNA in mouse model
RGD
PMID:33174006
RGD:155663372
NCBI chr10:118,046,821...118,210,153
Ensembl chr10:118,046,279...118,210,158
G
CASP12
caspase 12 (gene/pseudogene)
treatment
ISO
associated with Crush Injuries
RGD
PMID:30465396
RGD:34901874
NCBI chr11:104,883,286...104,898,460
Ensembl chr11:104,885,718...104,898,670
G
CASP3
caspase 3
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:32062619 PMID:29755641
RGD:13782288
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:29755641
RGD:13782288
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CAT
catalase
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:15612528
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CAV1
caveolin 1
treatment
ISO
RGD
PMID:24919947
RGD:10045573
NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179
G
CCL2
C-C motif chemokine ligand 2
ISO
mRNA, protein:increased expression:lung
RGD
PMID:21767135
RGD:6480432
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL4
C-C motif chemokine ligand 4
ISO
protein:increased expression:respiratory system fluid/secretion mRNA, protein:increased expression:lung
RGD
PMID:10679105 PMID:21906407 PMID:21767135
RGD:68880 , RGD:5683874 , RGD:6480432
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
G
CCR1
C-C motif chemokine receptor 1
ISO
associated with Pancreatitis
RGD
PMID:17312463
RGD:5688151
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
G
CD36
CD36 molecule (CD36 blood group)
ISO
associated with Malaria
RGD
PMID:18483551
RGD:6893505
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
associated with Sepsis;mRNA:increased expression:lung
RGD
PMID:10069420
RGD:5135253
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL2
C-X-C motif chemokine ligand 2
ISO EXP
mRNA, protein:increased expression:lung associated with Sepsis;mRNA:increased expression:lung protein:increased expression:respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27525872 PMID:15557650 PMID:10069420 PMID:19106808
RGD:5135247 , RGD:5135253 , RGD:5147925
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL5
C-X-C motif chemokine ligand 5
ISO
mRNA, protein:increased expression:lung associated with Reperfusion Injury
RGD
PMID:15557650 PMID:7814607
RGD:5135247 , RGD:5135256
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
G
CXCL6
C-X-C motif chemokine ligand 6
ISO
mRNA, protein:increased expression:lung associated with Reperfusion Injury
RGD
PMID:7814607 PMID:15557650
RGD:5135247 RGD:5135256
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
G
CXCL8
C-X-C motif chemokine ligand 8
disease_progression
IEP
associated with sepsis;protein:increased expression:blood serum (human)
RGD
PMID:28506137
RGD:40925937
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCR2
C-X-C motif chemokine receptor 2
treatment
ISO
associated with Pancreatitis
RGD
PMID:17014919
RGD:7257703
NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
mRNA:increased expression:lung
RGD
PMID:18367723 PMID:16882535
RGD:5135235 , RGD:5147744
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYSLTR1
cysteinyl leukotriene receptor 1
treatment
ISO
associated with Endotoxemia
RGD
PMID:27703200
RGD:40903067
NCBI chr X:78,271,468...78,327,611
Ensembl chr X:78,271,468...78,327,691
G
DDIT3
DNA damage inducible transcript 3
treatment
ISO
associated with Crush Injuries
RGD
PMID:30465396
RGD:34901874
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
EDN1
endothelin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16625121
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
EGFR
epidermal growth factor receptor
ISO
RGD
PMID:20935109
RGD:5131862
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
G
ELANE
elastase, neutrophil expressed
treatment
ISO
protein:increased expression:perfusate: associated with Shock, Hemorrhagic;
RGD
PMID:15257085 PMID:18283562 PMID:17203197
RGD:10450548 , RGD:10450585 , RGD:10450587
NCBI chr19:852,303...856,243
Ensembl chr19:851,014...856,247
G
EPHX1
epoxide hydrolase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26840748
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
G
EPHX2
epoxide hydrolase 2
ISO
RGD
PMID:22051199
RGD:5688354
NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564
G
ERN1
endoplasmic reticulum to nucleus signaling 1
treatment
ISO
associated with Crush Injuries
RGD
PMID:30465396
RGD:34901874
NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:22804886
RGD:7387313
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
G
F3
coagulation factor III, tissue factor
ISO
protein:increased expression: respiratory system fluid/secretion
RGD
PMID:21964405
RGD:11341740
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
G
FADD
Fas associated via death domain
treatment
ISO
associated with Shock, Hemorrhagic
RGD
PMID:24122010
RGD:11341811
NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390
G
FAS
Fas cell surface death receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:11778176
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FASLG
Fas ligand
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:11778176
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
FCGR1A
Fc gamma receptor Ia
ISO
RGD
PMID:19106808
RGD:5147925
NCBI chr 1:149,782,694...149,800,609
Ensembl chr 1:149,782,671...149,791,675
G
FCGR2A
Fc gamma receptor IIa
ISO
RGD
PMID:19106808
RGD:5147925
NCBI chr 1:161,505,457...161,524,048
Ensembl chr 1:161,505,430...161,524,013
G
FCGR2B
Fc gamma receptor IIb
treatment
ISO
RGD
PMID:19106808
RGD:5147925
NCBI chr 1:161,647,243...161,678,654
Ensembl chr 1:161,663,143...161,678,654
G
FGA
fibrinogen alpha chain
ISO
protein:increased expression:blood (rat)
RGD
PMID:22804886
RGD:7387313
NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,126...154,590,742
G
FLT1
fms related receptor tyrosine kinase 1
ISO
associated with Endotoxemia
RGD
PMID:21528367
RGD:5684427
NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
G
FOXA1
forkhead box A1
ISO
mRNA,protein:increased expression:lung
RGD
PMID:19649697
RGD:151665511
NCBI chr14:37,589,552...37,595,249
Ensembl chr14:37,589,552...37,596,059
G
GJA1
gap junction protein alpha 1
treatment
ISO
RGD
PMID:23576849
RGD:8662452
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
G
GOT1
glutamic-oxaloacetic transaminase 1
ISO
protein:decreased expression:lung (rat)
RGD
PMID:25581610
RGD:13504847
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
G
GSR
glutathione-disulfide reductase
ISO
RGD
PMID:7896613
RGD:7257562
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
GZMB
granzyme B
ISO
RGD
PMID:20018616
RGD:5135517
NCBI chr14:24,630,954...24,634,190
Ensembl chr14:24,630,954...24,634,267
G
HMGB1
high mobility group box 1
treatment
ISO
associated with Endotoxemia associated with Burns associated with Crush Injuries
RGD
PMID:19766246 PMID:23874764 PMID:30465396
RGD:4892587 , RGD:10402098 , RGD:34901874
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:16922808
RGD:5508470
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
G
HMOX1
heme oxygenase 1
treatment
ISO
associated with Reperfusion Injury
RGD
PMID:20850789 PMID:20360627
RGD:4145326 , RGD:4140418
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HNRNPC
heterogeneous nuclear ribonucleoprotein C
ISO
protein:altered localization:lung (mouse)
RGD
PMID:19029002
RGD:10054390
NCBI chr14:21,209,147...21,269,442
Ensembl chr14:21,209,136...21,269,494
G
HSPA5
heat shock protein family A (Hsp70) member 5
treatment
ISO
associated with Crush Injuries
RGD
PMID:30465396
RGD:34901874
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17973899 PMID:27525872 PMID:20569121
RGD:8547719
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IDO1
indoleamine 2,3-dioxygenase 1
treatment
ISO
RGD
PMID:25278421
RGD:39939031
NCBI chr 8:39,913,891...39,928,790
Ensembl chr 8:39,902,275...39,928,790
G
IFNG
interferon gamma
ISO
RGD
PMID:21767135
RGD:6480432
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IL10
interleukin 10
treatment no_association
ISO IAGP
associated with Reperfusion Injury;protein:increased expression:lung, plasma DNA:SNP:promoter:-1082G>A (rs1800896) (human) DNA:SNP:promoter:rs3021097 (human)
RGD
PMID:23902576 PMID:23801594 PMID:30412745 PMID:30412745
RGD:7364984 , RGD:7365008 , RGD:14975158 , RGD:14975158
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL13
interleukin 13
ISO
mRNA:increased expression:lung
RGD
PMID:15461830
RGD:4145512
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL17A
interleukin 17A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28600744
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL18
interleukin 18
treatment
ISO
associated with Myocardial Reperfusion Injury
RGD
PMID:24223666
RGD:8655952
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1B
interleukin 1 beta
ISO EXP
protein:increased expression:serum protein:increased expression:lung mRNA, protein:increased expression:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:32062619 PMID:20663306 PMID:20153312 PMID:8613550 PMID:21767135 PMID:22982561 More...
RGD:4142531 , RGD:4142807 , RGD:4143193 , RGD:6480432 , RGD:7204498
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RL1
interleukin 1 receptor like 1
ISO EXP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:21352201 PMID:21352201
RGD:5144222
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
G
IL1RN
interleukin 1 receptor antagonist
ISO
mRNA:increased expression:lung
RGD
PMID:15970097 PMID:8613550
RGD:4143168 , RGD:4143193
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL2
interleukin 2
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:21767135
RGD:6480432
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
IL22
interleukin 22
ISO
RGD
PMID:20498020
RGD:4888524
NCBI chr12:68,248,242...68,253,604
Ensembl chr12:68,248,242...68,253,604
G
IL4
interleukin 4
treatment
ISO
RGD
PMID:24681349
RGD:10402798
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL4I1
interleukin 4 induced 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:36537648
NCBI chr19:49,889,654...49,929,504
Ensembl chr19:49,889,654...49,929,539
G
IL6
interleukin 6
ISO EXP
protein:increased expression:bronchoalveolar lavage, blood, lung (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:32062619 PMID:19995278
RGD:11062103
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IRAK3
interleukin 1 receptor associated kinase 3
ISO
mRNA, protein:increased expression:lung (mouse)
RGD
PMID:21577093
RGD:36049795
NCBI chr12:66,189,214...66,254,622
Ensembl chr12:66,189,195...66,254,622
G
ITGAM
integrin subunit alpha M
treatment
ISO
associated with Hemorrhagic Shock
RGD
PMID:1347308 PMID:16096539
RGD:329901922 , RGD:329901935
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
G
ITGB2
integrin subunit beta 2
ISO
RGD
PMID:1374449
RGD:6482199
NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989
G
JAK3
Janus kinase 3
ISO
RGD
PMID:22359619
RGD:11531100
NCBI chr19:17,824,782...17,847,982
Ensembl chr19:17,824,780...17,848,071
G
KDR
kinase insert domain receptor
ISO
associated with Endotoxemia;mRNA, protein:decreased expression:lung
RGD
PMID:21528367
RGD:5684427
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
G
LTB4R2
leukotriene B4 receptor 2
severity
ISO
associated with Endotoxemia
RGD
PMID:27703200
RGD:40903067
NCBI chr14:24,310,140...24,312,038
Ensembl chr14:24,305,734...24,312,053
G
MFN1
mitofusin 1
ISO
mRNA, protein:altered expression:lung (rat)
RGD
PMID:25560372
RGD:12437080
NCBI chr 3:179,347,709...179,394,936
Ensembl chr 3:179,347,709...179,394,936
G
MFN2
mitofusin 2
ISO
mRNA, protein:increased expression:lung (rat)
RGD
PMID:25560372
RGD:12437080
NCBI chr 1:11,980,444...12,013,508
Ensembl chr 1:11,980,181...12,015,211
G
MIR155
microRNA 155
treatment
ISO
associated with Sepsis associated with sepsis;miRNA:increased expression:lung
RGD
PMID:30220274 PMID:31949845 PMID:28125526 PMID:27371731 PMID:27371731
RGD:21066348 , RGD:21408593 , RGD:24922218 , RGD:11566124 , RGD:11566124
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MIR21
microRNA 21
ISO
RNA:increased expression:lung
RGD
PMID:30542412
RGD:41410885
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
G
MIR223
microRNA 223
severity treatment
ISO
RGD
PMID:28931657 PMID:32226458
RGD:21408568 , RGD:26884341
NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979
G
MIR330
microRNA 330
ISO
associated with Disseminated Intravascular Coagulation;RNA:increased expression:lung:
RGD
PMID:24806323
RGD:11553933
NCBI chr19:45,638,994...45,639,087
Ensembl chr19:45,638,994...45,639,087
G
MIR483
microRNA 483
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32062619
NCBI chr11:2,134,134...2,134,209
Ensembl chr11:2,134,134...2,134,209
G
MIR96
microRNA 96
ISO
associated with Disseminated Intravascular Coagulation;RNA:increased expression:lung:
RGD
PMID:24806323
RGD:11553933
NCBI chr 7:129,774,692...129,774,769
Ensembl chr 7:129,774,692...129,774,769
G
MIR99B
microRNA 99b
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:33109608
NCBI chr19:51,692,612...51,692,681
Ensembl chr19:51,692,612...51,692,681
G
MMP2
matrix metallopeptidase 2
ISO
RGD
PMID:23040778
RGD:13207316
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP7
matrix metallopeptidase 7
ISO
associated with Sepsis
RGD
PMID:21567117
RGD:9685338
NCBI chr11:102,520,508...102,530,747
Ensembl chr11:102,520,508...102,530,750
G
MMP9
matrix metallopeptidase 9
ISO
RGD
PMID:23040778
RGD:13207316
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MPO
myeloperoxidase
ISO
associated with Kidney Reperfusion Injury; protein:increased activity:lung
RGD
PMID:22092133
RGD:6909173
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
MT1X
metallothionein 1X
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16166738
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
G
MT2A
metallothionein 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16166738
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
G
MYLK
myosin light chain kinase
IAGP EXP
associated with Sepsis CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19374788 PMID:16399953
RGD:1581052
NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332
G
NEAT1
nuclear paraspeckle assembly transcript 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:34687491
NCBI chr11:65,422,798...65,445,540
Ensembl chr11:65,422,774...65,445,540
G
NFE2L2
NFE2 like bZIP transcription factor 2
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:24812154
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NGF
nerve growth factor
ISO
RGD
PMID:17673270
RGD:5144065
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NLRP3
NLR family pyrin domain containing 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:33012731
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,332,331...247,449,108
G
NOD2
nucleotide binding oligomerization domain containing 2
treatment
ISO
associated with Sepsis
RGD
PMID:22575870
RGD:8547530
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
G
NOS2
nitric oxide synthase 2
ISO
RGD
PMID:16882535
RGD:5147744
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NPPA
natriuretic peptide A
IDA
RGD
PMID:23422200
RGD:7247713
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
G
NQO1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
RGD
PMID:24669282 PMID:28065220
RGD:11035223 , RGD:13442501
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
OPA1
OPA1 mitochondrial dynamin like GTPase
ISO
mRNA, protein:altered expression:lung (rat)
RGD
PMID:25560372
RGD:12437080
NCBI chr 3:193,593,208...193,697,811
Ensembl chr 3:193,593,144...193,697,811
G
P2RY12
purinergic receptor P2Y12
ISO
associated with Shock, Hemorrhagic
RGD
PMID:21841533
RGD:6480522
NCBI chr 3:151,336,843...151,384,753
Ensembl chr 3:151,336,843...151,384,753
G
PAK1
p21 (RAC1) activated kinase 1
ISO
DNA:hypermethylation
RGD
PMID:23546543
RGD:11533951
NCBI chr11:77,322,017...77,530,009
Ensembl chr11:77,322,017...77,474,635
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
associated with Pancreatitis, Experimental, Acute
RGD
PMID:16127429
RGD:11075069
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PAWR
pro-apoptotic WT1 regulator
ISO
mRNA,protein:increased expression:lung,blood vessel:
RGD
PMID:17136598
RGD:9835397
NCBI chr12:79,584,879...79,690,964
Ensembl chr12:79,574,979...79,690,964
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
RGD
PMID:22592748
RGD:6483494
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
G
PFKFB3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
ISO
associated with Endotoxemia;mRNA, protein:increased expression:lung (mouse)
RGD
PMID:31167111
RGD:41410778
NCBI chr10:6,144,921...6,326,637
Ensembl chr10:6,144,934...6,254,644
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
ISO
associated with endotoxemia
RGD
PMID:22198681 PMID:11714830
RGD:6482677 , RGD:38599213
NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980
G
PLA2G2A
phospholipase A2 group IIA
severity
ISO
RGD
PMID:19235614
RGD:6482722
NCBI chr 1:19,975,431...19,980,434
Ensembl chr 1:19,975,431...19,980,416
G
PLAU
plasminogen activator, urokinase
treatment
ISO
associated with Endotoxemia
RGD
PMID:21473829 PMID:23324284
RGD:5147760 , RGD:7241552
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PPARG
peroxisome proliferator activated receptor gamma
ISO EXP
protein:decreased expression:lung (rat) CTD Direct Evidence: therapeutic
CTD RGD
PMID:21153920 PMID:16083301
RGD:8553030
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PRDM1
PR/SET domain 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:33109608
NCBI chr 6:105,992,690...106,109,938
Ensembl chr 6:105,993,463...106,109,939
G
PRKAA1
protein kinase AMP-activated catalytic subunit alpha 1
ISO
RGD
PMID:21595935
RGD:6484539
NCBI chr 5:40,759,389...40,798,374
Ensembl chr 5:40,759,389...40,798,374
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
treatment
IDA
associated with Pseudomonas Infections associated with Intestinal Reperfusion Injury
RGD
PMID:16553944 PMID:18367148
RGD:11100043 , RGD:11250405
NCBI chr 2:127,418,427...127,429,242
Ensembl chr 2:127,418,427...127,429,242
G
PROCR
protein C receptor
treatment
ISO
RGD
PMID:20095324
RGD:13515130
NCBI chr20:35,171,096...35,216,259
Ensembl chr20:35,172,072...35,216,240
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
protein:increased expression:lung
RGD
PMID:20926798 PMID:19567182
RGD:5135287 , RGD:5135496
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
SCGB1A1
secretoglobin family 1A member 1
ISO
protein:decreased expression:lung
RGD
PMID:18420837 PMID:16226776
RGD:5143982 , RGD:5144142
NCBI chr11:62,419,033...62,423,195
Ensembl chr11:62,405,103...62,423,195
G
SERPINC1
serpin family C member 1
treatment
IDA
associated with Endotoxemia
RGD
PMID:17940748
RGD:11035256
NCBI chr 1:173,903,800...173,917,327
Ensembl chr 1:173,903,800...173,917,327
G
SERPINE1
serpin family E member 1
treatment
ISO
associated with Sepsis associated with Shock, Hemorrhagic;mRNA:increased expression:lung (rat)
RGD
PMID:25934465 PMID:18182560 PMID:10745022
RGD:11075078 , RGD:11080962 , RGD:11080967
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SERPING1
serpin family G member 1
treatment
IDA
RGD
PMID:11685347
RGD:8661650
NCBI chr11:57,597,685...57,614,848
Ensembl chr11:57,597,387...57,619,171
G
SFTPA1
surfactant protein A1
IEP
mRNA, protein:increased expression:pneumocyte
RGD
PMID:8569184
RGD:4143451
NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,939...79,615,455
G
SFTPB
surfactant protein B
treatment
ISO
RGD
PMID:22295533
RGD:151667443
NCBI chr 2:85,657,307...85,668,741
Ensembl chr 2:85,657,314...85,668,741
G
SFTPD
surfactant protein D
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:30060251
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
G
SIRT2
sirtuin 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32063085
NCBI chr19:38,878,555...38,899,618
Ensembl chr19:38,878,555...38,899,862
G
SLPI
secretory leukocyte peptidase inhibitor
severity treatment
ISO
associated with Endotoxemia
RGD
PMID:10092827 PMID:25466948
RGD:9999422 , RGD:9999425
NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564
G
TAC1
tachykinin precursor 1
ISO
RGD
PMID:19797759
RGD:5147812
NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
G
TACR1
tachykinin receptor 1
ISO
mRNA:increased expression:lung
RGD
PMID:18523300
RGD:5147819
NCBI chr 2:75,046,463...75,199,520
Ensembl chr 2:75,046,463...75,199,520
G
TFF1
trefoil factor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19880587
NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535
G
TFF2
trefoil factor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19880587
NCBI chr21:42,346,357...42,350,994
Ensembl chr21:42,346,357...42,350,997
G
TGFB1
transforming growth factor beta 1
treatment
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16100012 PMID:25278421
RGD:39939031
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
THBD
thrombomodulin
treatment
ISO IMP
associated with Endotoxemia
RGD
PMID:19342415 PMID:19536047 PMID:20095324
RGD:5131887 , RGD:5685372 , RGD:13515130
NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
G
TIMP2
TIMP metallopeptidase inhibitor 2
severity
ISO
RGD
PMID:10092827
RGD:9999422
NCBI chr17:78,852,977...78,925,387
Ensembl chr17:78,852,977...78,925,387
G
TLR4
toll like receptor 4
ISO
RGD
PMID:19567182
RGD:5135496
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNF
tumor necrosis factor
no_association treatment
ISO IAGP EXP
mRNA, protein:increased expression:lung protein:increased expression:respiratory system fluid/secretion DNA:SNP:promoter:-308G>A (rs1800629) (human) DNA:SNP:promoter:rs1799964 (human) associated with Liver Reperfusion Injury CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:34390737 PMID:21767135 PMID:19106808 PMID:30412745 PMID:30412745 PMID:11129814 More...
RGD:6480432 , RGD:5147925 , RGD:14975158 , RGD:14975158 , RGD:14995473
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFAIP6
TNF alpha induced protein 6
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:26313688
NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046
G
TREM1
triggering receptor expressed on myeloid cells 1
exacerbates ameliorates
ISO
RGD
PMID:26832696 PMID:26832696
RGD:127284840 , RGD:127284840
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,926...41,286,682
G
TXN
thioredoxin
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:16298680
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
G
USP18
ubiquitin specific peptidase 18
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:33930521
NCBI chr22:18,150,170...18,177,397
Ensembl chr22:18,149,843...18,177,397
G
VEGFA
vascular endothelial growth factor A
ISO
associated with Endotoxemia;mRNA, protein:altered expression:lung, plasma
RGD
PMID:21528367
RGD:5684427
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VIP
vasoactive intestinal peptide
ISO EXP
associated with Endotoxemia CTD Direct Evidence: therapeutic
CTD RGD
PMID:8643465 PMID:20441697
RGD:4145303
NCBI chr 6:152,750,797...152,759,760
Ensembl chr 6:152,750,797...152,759,765
G
XDH
xanthine dehydrogenase
treatment
ISO
RGD
PMID:9655743
RGD:13209002
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
G
ZC3H12A
zinc finger CCCH-type containing 12A
severity
ISO
associated with toxic shock syndrome
RGD
PMID:23422584
RGD:39938961
NCBI chr 1:37,474,580...37,484,377
Ensembl chr 1:37,474,580...37,484,377
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all